Skip to Main Content

Author Details

Thomas A Hope
University of California san francisco
2007
213
48
PMIDPaper TitleJournal TitlePublished Year
36932225Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology.Abdom Radiol (NY)2023
37591547Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers.J Nucl Med2023
37624384International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology.Eur J Nucl Med Mol Imaging2023
37482512Presurgical <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography for Biochemical Recurrence Risk Assessment: A Follow-up Analysis of a Multicenter Prospective Phase 3 Imaging Trial.Eur Urol2023
37290800SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-PSMA-617 Radionuclide Therapy.J Nucl Med2023
37255328Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.J Natl Cancer Inst2023
37246997Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT).Eur J Nucl Med Mol Imaging2023
37414701Prostate-specific Membrane Antigen Reporting and Data System Version 2.0.Eur Urol2023
37208512Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas.Br J Cancer2023
37145311Rectal cancer lexicon 2023 revised and updated consensus statement from the Society of Abdominal Radiology Colorectal and Anal Cancer Disease-Focused Panel.Abdom Radiol (NY)2023
37203346Editorial Comment.J Urol2023
37002881Baseline tumor growth rate highlights the heterogeneity of well differentiated gastroenteropancreatic neuroendocrine tumors and predicts for increases in Ki67 index over time.J Neuroendocrinol2023
37230530<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective Study.J Nucl Med2023
36997329PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study.J Nucl Med2023
37062021PET/MRI in colorectal and anal cancers: an update.Abdom Radiol (NY)2023
36725249SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.J Nucl Med2023
36693228Systemic Therapy Update on <sup>177</sup>Lutetium-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: ASCO Guideline Rapid Recommendation Q and A.JCO Oncol Pract2023
36473945Using PSMA imaging for prognostication in localized and advanced prostate cancer.Nat Rev Urol2023
36435709Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers.Urol Oncol2023
36935345Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).Eur Urol2023
36737523Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios.Abdom Radiol (NY)2023
36604326PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.Eur J Nucl Med Mol Imaging2023
34340823A cost-utility analysis of 18F-fluorocholine-positron emission tomography imaging for localizing primary hyperparathyroidism in the United States.Surgery2022
35507433ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.Clin Nucl Med2022
35507413ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.Am J Clin Oncol2022
35649195Neuroendocrine Tumors and Peptide Receptor Radionuclide Therapy: When Is the Right Time?J Clin Oncol2022
35348001Impact of Implicit Abdominal Aortic Aneurysm Screening in the Veterans Affairs Health Care System Over 10 Years.J Am Heart Assoc2022
35732972Imaging joint infections using D-methyl-<sup>11</sup>C-methionine PET/MRI: initial experience in humans.Eur J Nucl Med Mol Imaging2022
35503984Best Approaches and Updates for Prostate Cancer Biochemical Recurrence.Am Soc Clin Oncol Educ Book2022
35361712Leadership in Patient Advocacy: A Conversation Between Josh Mailman and Thomas Hope.J Nucl Med2022
35487567Updates to Appropriate Use Criteria for PSMA PET.J Nucl Med2022
35618479Choice Is Good at Times: The Emergence of [<sup>64</sup>Cu]Cu-DOTATATE-Based Somatostatin Receptor Imaging in the Era of [<sup>68</sup>Ga]Ga-DOTATATE.J Nucl Med2022
36551678Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET.Cancers (Basel)2022
36178531Impact of radiopharmaceutical therapy (<sup>177</sup>Lu, <sup>225</sup>Ac) microdistribution in a cancer-associated fibroblasts model.EJNMMI Phys2022
35015566Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.J Clin Oncol2022
35273095Reply: Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.J Nucl Med2022
35175289PSMA PET in Prostate Cancer-A Biomarker or a Surrogate End Point?-Reply.JAMA Oncol2022
35114134Dosimetry in radionuclide therapy: the clinical role of measuring radiation dose.Lancet Oncol2022
35301240The PRIMARY Score: Using Intraprostatic <sup>68</sup>Ga-PSMA PET/CT Patterns to Optimize Prostate Cancer Diagnosis.J Nucl Med2022
34896918Discovery and characterization of circulating tumor cell clusters in neuroendocrine tumor patients using nanosubstrate-embedded microchips.Biosens Bioelectron2022
34736838Preoperative risk stratification of lymph node metastasis for non-functional pancreatic neuroendocrine neoplasm: An international dual-institutional study.Pancreatology2022
34815096Response to "Preoperative localization in primary hyperparathyroidism: Views from the developing world".Surgery2022
34620731PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study.J Nucl Med2022
34593595Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging.J Nucl Med2022
34301784A Path to Qualification of PET/MRI Scanners for Multicenter Brain Imaging Studies: Evaluation of MRI-Based Attenuation Correction Methods Using a Patient Phantom.J Nucl Med2022
34326126A Comprehensive Assessment of <sup>68</sup>Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients.J Nucl Med2022
34301418Superior sensitivity of <sup>18</sup>F-fluorocholine: PET localization in primary hyperparathyroidism.Surgery2022
32513903Intraarterial Peptide Receptor Radionuclide Therapy Using <sup>90</sup>Y-DOTATOC for Hepatic Metastases of Neuroendocrine Tumors.J Nucl Med2021
33685867High-Specific-Activity-<sup>131</sup>I-MIBG versus <sup>177</sup>Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.Clin Cancer Res2021
33741646Reply: Disparities in PET Imaging of Prostate Cancer at a Tertiary Academic Medical Center.J Nucl Med2021
  • 1 - 50 of 213

Recommended Authors

Randy Yeh
Department of Radiology Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 3
Anthony Sisk
University of California los angeles
Career Start Year 2017
Number of shared co-authors 10
Stephanie A Lee-Felker
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 2012
Number of shared co-authors 4
Sohrab Afshari Mirak
University Hospitals Cleveland Medical Center/Case Western Reserve University
Career Start Year 2011
Number of shared co-authors 2
Vincent Dunet
Lausanne University Hospital and University of Lausanne
Career Start Year 2011
Number of shared co-authors 0
Raquel Perez-Lopez
Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus
Career Start Year 2010
Number of shared co-authors 8
Michael A Morris
Clinical Center, National Institutes of Health
Career Start Year 2009
Number of shared co-authors 7
Pedram Heidari
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 4
Nelly Tan
Department of Radiology at the Mayo Clinic Hospital in Phoenix
Career Start Year 2007
Number of shared co-authors 3
Pardeep Kumar
National Institute of Mental Health & Neurosciences (NIMHANS)
Career Start Year 2005
Number of shared co-authors 0
Guido Davidzon
Stanford University
Career Start Year 2005
Number of shared co-authors 1
Nina Tunariu
The Institute of Cancer Research
Career Start Year 2005
Number of shared co-authors 8
Daniel J Margolis
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 9
Seung Hong Choi
Seoul National University Hospital
Career Start Year 2003
Number of shared co-authors 0
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Career Start Year 2002
Number of shared co-authors 4
Zhaohui Zhu
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2000
Number of shared co-authors 2
Chuong Bui
Nepean Hospital
Career Start Year 1999
Number of shared co-authors 0
Alda L Tam
MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 0
Nobuyuki Kosaka
University of Fukui.
Career Start Year 1997
Number of shared co-authors 2
Amita Shukla-Dave
Memorial Sloan Kettering Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Richard K G Do
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 4
Masoom A Haider
University Health Network
Career Start Year 1995
Number of shared co-authors 5
Bradford J Wood
National Cancer Institute, National Institutes of Health
Career Start Year 1995
Number of shared co-authors 11
Baixuan Xu
First Medical Center, Chinese PLA General Hospital
Career Start Year 1994
Number of shared co-authors 2
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 4
Elizabeth C Jones
Clinical Center, National Institutes of Health
Career Start Year 1989
Number of shared co-authors 8
Marcelino Bernardo
Center for Interventional Oncology, National Institutes of Health
Career Start Year 1982
Number of shared co-authors 3
Jiahe Tian
First Medical Center of Chinese PLA General Hospital
Career Start Year 1982
Number of shared co-authors 2
Ely R Felker
University of California, Los Angeles David Geffen School of Medicine
Career Start Year 1973
Number of shared co-authors 8
Ida Sonni
David Geffen School of Medicine at university of california los angeles
Career Start Year 1968
Number of shared co-authors 6

Collaborators

Jeremie Calais
university of california los angeles
Co-authored papers 30
Spencer C Behr
University of California san francisco
Co-authored papers 18
Johannes Czernin
university of california los angeles
Co-authored papers 18
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 16
Peder E Z Larson
University of California San Francisco
Co-authored papers 14
Youngho Seo
University of California san francisco
Co-authored papers 11
Eric J Small
University of California san francisco
Co-authored papers 10
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 9
Rahul Aggarwal
University of California San Francisco
Co-authored papers 9
Jaewon Yang
University of California san francisco
Co-authored papers 8
Heiko Sch??der
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
John J Sunderland
University of Iowa
Co-authored papers 5
David C Metz
Abramson Cancer Center, University of Pennsylvania
Co-authored papers 5
Tobias Maurer
Martini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Co-authored papers 5
Jennifer A Chan
Dana-Farber Cancer Institute
Co-authored papers 5
Iva Petkovska
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Neeta Pandit-Taskar
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Michael J Morris
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Andrei Gafita
Johns Hopkins University School of Medicine
Co-authored papers 4
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 4
Lauren Boreta
Co-authored papers 4
Bridget F Koontz
Duke University School of Medicine
Co-authored papers 3
Javier E Villanueva-Meyer
University of California san francisco
Co-authored papers 3
Alison Knauth Meadows
Kaiser San Francisco Medical Center
Co-authored papers 3
Babak Saboury
Clinical Center
Co-authored papers 3
William P Dillon
Co-authored papers 3
Kathleen Nguyen
Co-authored papers 3
Amar U Kishan
University of California los angeles
Co-authored papers 3
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 3
Lawrence Fong
University of California san francisco
Co-authored papers 3
Release 1.2